Donna Flesher

Donna Flesher has a diverse work experience spanning multiple industries and roles. Donna currently serves as VP of Biomarker and Bioanalytical Sciences at HIBio since January 2022. Prior to that, they held various positions at Amgen, where they were the Head of Oncology Clinical Biomarkers from May 2019 to January 2022. Donna also worked as a Principal Scientist and Solid Tumor I/O Therapeutic Area Lead from July 2017 to May 2019, as well as a Senior Scientist from March 2015 to July 2017. Donna began their career at Amgen as a Scientist/Senior Scientist from November 2010 to March 2015.

Donna's previous experience includes roles at Genentech as a Postdoc from June 2007 to October 2010 and at Stanford University where they were a Ph.D. Student in Immunology from September 2001 to June 2007. During their time at Stanford, Donna also served as an Instructor at UC Berkeley Extension from June 2009 to June 2011.

Furthermore, Donna has been actively involved in the community. Donna was a member of the Board of Directors at Rape Trauma Services of San Mateo County since January 2006 and served as the Chair of the Board of Directors from July 2009 to July 2011.

Donna Flesher completed their Bachelor of Science degree in Biotechnology from Rochester Institute of Technology from 1997 to 2001. Subsequently, they pursued a Ph.D. in Immunology from Stanford University School of Medicine, where they earned their degree from 2001 to 2007.